Bullous pemphigoid complicating human orf disease
DOI:
https://doi.org/10.66344/jpad.v28i3.1104Keywords:
Orf, bullous pemphigoid, orf-induced immunobullous diseaseAbstract
Orf is a zoonosis caused by Parapoxvirus and transmitted to human by sheep. Bullous pemphigoid has been reported as an occasional complication following orf. We report a 51-year-old female who developed bullous pemphigoid 3 weeks following orf. The case is reported for its rare co-occurrence
References
1. Ozturk P, Sayar H, Karakas T, Akman Y. Erythema multiforme as a result of orf disease. Acta Dermatovenerologica Alp Pannonica Adriat. 2012;21:45-6.
2. Shahmoradi Z, Abtahi-Naeini B, Pourazizi, M, Meidani M. Orf disease following “Eid ul-Adha”: A rare cause of erythema multiforme. Int J Prev Med. 2014;5:912-4.
3. Agger WA, Webster SB. Human orf infection complicated by erythema multiforme. Cutis. 2014;31:334-8.
4. Alian S, Ahangarkani F, Arabsheybani S. A case of orf disease complicated with erythema multiforme and bullous pemphigoid-like eruptions. Case Rep Infect Dis. 2015;2015:105484.
5. White KP, Zedek DC, White WL, Simpson EL, Hester E, Morrison L et al. Orf-induced immunobullous disease: A distinct autoimmune blistering disorder. J Am Acad Dermatol. 2008;58:49-55.
6. Murphy JK, Ralfs IG. Bullous pemphigoid complicating human orf. Br J Dermatol. 2008;134:929-30.
7. Van Lingen RG, Frank RGJ, Koopman RJJ, Jonkman MF. Human orf complicated by mucous membrane pemphigoid. Clin Exp Dermatol. 2006;31:711-2.
8. Avci A, Avci D, Turasan A, Çınar SL. Orfun İndüklediği Büllöz Pemfigoid Olgusu. Turk J Dermatol. 2013;7:91-2.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Zerrin Ogretmen, Ceren Gül, Alper Ekinci, Taner Akalın

This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.






